376900 — Rokit Healthcare Income Statement
0.000.00%
- KR₩240bn
- KR₩287bn
- KR₩13bn
Annual income statement for Rokit Healthcare, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 6,741 | 9,151 | 12,418 | 13,111 |
Cost of Revenue | ||||
Gross Profit | 1,655 | 3,104 | 4,047 | 5,983 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 24,043 | 22,938 | 19,500 | 18,717 |
Operating Profit | -17,302 | -13,788 | -7,083 | -5,606 |
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -56,284 | 2,027 | 16,831 | -7,337 |
Provision for Income Taxes | ||||
Net Income After Taxes | -56,393 | 1,857 | 16,627 | -7,690 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | -56,247 | 1,875 | 16,600 | -7,646 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -56,247 | 1,875 | 16,600 | -7,646 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -5,844 | 186 | 1,695 | -792 |
Dividends per Share |